NCT00357084View on ClinicalTrials.gov

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2007

Conditions
Cancer
Interventions
DRUG

methotrexate

DRUG

methylprednisolone

DRUG

prednisone

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00357084 - Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant | Biotech Hunter | Biotech Hunter